Evidence map›Paper›PMID 34527333›Full record

ArticleJournal of thoracic disease2021

Change in amount smoked and readiness to quit among patients undergoing lung cancer screening.

Danielle E Deros, Charlotte J Hagerman, Jenna A Kramer, Eric D Anderson, Shawn Regis, Andrea B McKee, Brady J McKee, Cassandra A Stanton, Ray Niaura, David B Abrams and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Danielle E DerosCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Charlotte J HagermanCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Jenna A KramerLevine Cancer Institute, Carolinas Healthcare System, Charlotte, NC, USA.
Eric D AndersonMedstar Georgetown University Medical Center, Washington, DC, USA.
Shawn RegisSophia Gordon Cancer Center, Lahey Hospital and Medical Center, Burlington, MA, USA.
Andrea B McKeeSophia Gordon Cancer Center, Lahey Hospital and Medical Center, Burlington, MA, USA.
Brady J McKeeSophia Gordon Cancer Center, Lahey Hospital and Medical Center, Burlington, MA, USA.
Cassandra A StantonCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Ray NiauraCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
David B AbramsCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Michael RamsaierJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Shelby FallonCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Harry HarperJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Kathryn L TaylorCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Georgetown University · USGeorgetown University Medical Center · USLahey Medical Center · USHackensack University Medical Center · USLevine Cancer Institute · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
Integrating Evidence-Based Smoking Cessation Interventions into Lung Cancer Screening Programs: A Randomized TrialR01CA207228 · NCI · GEORGETOWN UNIVERSITY · PI TAYLOR, KATHRYN L · 2016 to 2020
$3.5M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA207228
6 · The paper itself

Abstract

backgroundThere is mixed evidence regarding whether undergoing computed tomography lung cancer screening (LCS) can serve as a "teachable moment" that impacts smoking behavior and attitudes. The study aim was to assess whether the standard procedures of undergoing LCS and receiving free and low-cost evidence-based cessation resources impacted short-term smoking-related outcomes.

methodsParticipants were smokers (N=87) who were registered to undergo lung screening and were enrolled in a cessation intervention trial. We conducted two phone interviews, both preceding trial randomization: the first interview was conducted prior to lung screening, and the second interview followed lung screening (median =12.5 days post-screening) and participants' receipt of their screening results. The interviews assessed demographic characteristics, interest in evidence-based cessation intervention methods, and tobacco-related characteristics, including cigarettes per day and readiness to quit. Participants received minimal evidence-based cessation resources following the pre-lung screening interview.

resultsParticipants were 60.3 years old, 56.3% female, and reported a median of 40 pack-years. Participants were interested in using several evidence-based strategies, including counseling from a healthcare provider (76.7%) and receiving nicotine replacement therapy (69.8%). Pre-lung screening, 25.3% smoked ≤10 cigarettes per day, and 29.9% were ready to quit in the next 30 days. We conducted two McNemar binomial distribution tests to assess change from pre- to post-screening. At the post-lung screening assessment, approximately three-quarters reported no change on these variables. However, 23.3% reported smoking fewer cigarettes per day, whereas 4.7% reported smoking more cigarettes per day (McNemar P=0.002), and 17.2% reported increased readiness to quit, whereas 6.9% reported decreased readiness to quit (McNemar P=0.078).

conclusionsFollowing receipt of cessation resources and completion of lung screening, most participants reported no change in smoking outcomes. However, there was a significant reduction in cigarettes per day, and there was a trend for increased readiness to quit. This setting may provide a potential "teachable moment" and an opportunity to assist smokers with quitting. However, more proactive and intensive interventions will be necessary to capitalize on these changes and to support abstinence in the long-term.

Indexed as

CT lung cancer screening (CT LCS)Lung cancersmoking behaviorsteachable momenttobacco

Identifiers

PMID34527333
PMCPMC8411192
OpenAlexW3195762221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.